![[Toyota Times] From Strengthening Foundations to Boosting Productivity - Toyota Focuses on Break-Even Volume](https://businessfortnight.com/wp-content/uploads/2025/11/Toyota-Times-From-Strengthening-Foundations-to-Boosting-Productivity-Toyota-218x150.jpg "[Toyota Times] From Strengthening Foundations to Boosting Productivity – Toyota Focuses on Break-Even Volume")
Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the international chief in blood quantity measurement know-how, broadcasts immediately that CEO and President Michael Feldschuh will attend the H.C. Wainwright 24th Annual Global Investment Conference being held on September 12 – 14, 2022 at the Lotte New York Palace.
Mr. Feldschuh can be out there for one-on-one conferences. To request a gathering and to register for the convention, click on: https://hcwevents.com/annualconference/
Interested traders might also contact Bret Shapiro at CORE IR both by calling 1-516-222-2560 or emailing [email protected].
About Daxor Corporation
Daxor Corporation (Nasdaq: DXR), is the international chief in blood quantity measurement know-how centered on blood quantity testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood take a look at cleared by the FDA to present protected, correct, goal quantification of blood quantity standing and composition in contrast to patient-specific norms. Over 60,000+ checks have been carried out at main hospital facilities throughout the U.S., enhancing hospital efficiency metrics in a broad vary of surgical and medical circumstances, together with considerably decreasing mortality and readmissions in coronary heart failure and demanding care. Daxor has a number of ongoing multicenter trials in the areas of COVID-19 and coronary heart failure therapy with help from the NIH and is below contract creating analyzers to enhance fight casualty care with the U.S. Department of Defense. Daxor’s mission is to advance healthcare by enabling optimum fluid administration with blood quantity evaluation. Daxor’s imaginative and prescient is perfect blood quantity for all. For extra info, please go to our web site at Daxor.com.
Forward-Looking Statements
Certain statements on this launch could embrace forward-looking statements inside the which means of the Private Securities Litigation Reform Act of 1995, together with with out limitation, statements concerning the influence of hiring gross sales workers and growth of our distribution channels. Forward-looking statements are predictions, projections and different statements about future occasions which are based mostly on present expectations and assumptions and, in consequence, are topic to dangers and uncertainties. Many components might trigger precise future occasions to differ materially from the forward-looking statements on this launch, together with, with out limitation, these danger related to our post-market medical information assortment actions, advantages of our merchandise to sufferers, our expectations with respect to product growth and commercialization efforts, our capacity to enhance market and doctor acceptance of our merchandise, probably aggressive product choices, mental property safety, FDA regulatory actions, our capacity to combine acquired companies, our expectations concerning anticipated synergies with and advantages from acquired companies, and extra different dangers and uncertainties described in our filings with the SEC. Forward-looking statements converse solely as of the date when made. Daxor doesn’t assume any obligation to publicly replace or revise any forward-looking statements, whether or not because of new info, future occasions or in any other case.
Investor Relations Contact:
Bret Shapiro
Sr. Managing Partner, CORE IR
1-516-222-2560
[email protected]
